Open access
Aug 2026
The Ca2+ channel Orai3 drives gemcitabine resistance in pancreatic cancer through NFATc1-dependent SLIT3 expression
Orai3 is revealed as a promising target to combat gemcitabine resistance and uncovers a unique Orai3-NFATc1-SLIT3 signaling module that drives chemoresistance.
Samriddhi Arora, Abhishek Tanwar, Gyan Ranjan et al.
· Journal of Biological Chemis... · 2 citations